China Pharma Holdings (CPHI) Total Debt (2010 - 2026)

China Pharma Holdings has reported Total Debt for 17 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt fell 24.25% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 24.25% YoY), and the FY2025 full-year result was $2.0 million, down 17.84% from the prior year.
• Total Debt for Q1 2026 stood at $1.9 million, down from $2.0 million in the prior quarter.
• The five-year high for Total Debt was $4.6 million in Q3 2022, with the low at $1.4 million in Q3 2025.
• Historically, Total Debt has averaged $2.7 million across 5 years, with a median of $2.5 million in 2024.
• Annual changes were most pronounced in 2022 — Total Debt jumped 49.52% — and 2023, when it sank 47.58%.
• China Pharma Holdings' Total Debt stood at $2.4 million in 2022, then rose by 4.29% to $2.5 million in 2023, then dropped by 5.46% to $2.4 million in 2024, then decreased by 17.84% to $2.0 million in 2025, then declined by 2.45% to $1.9 million in 2026.
• The last three Total Debt figures came in at $1.9 million (Q1 2026), $2.0 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.